1. Buchler T, Kovarova L, Musilova R, Bourkova L, Ocadlikova D, Bulikova A, Hanak L, Michalek J, Hajek R: Generation of dendritic cells using cell culture bags--description of a method and review of literature. Hematology, 9, 2004, 3,199-205. IF 1,267
2. Buchler T, Cervinek L, Belohlavek O, Kantorova, Mechl M, Nebesky T, Vorlicek J, Adam Z: Brief Report. Lagerhans Cell Histiocytosis With Central Nervous System Involvement: Up by FDG-PET During Treatment With Cladribine.Pediatr Blood Cancer, 43, 2004,1-3. IF 1,73 Zjišťeno od dr. Buchlera
3. Doubek M, Brychtova Y, Doubek R, Janku P, Mayer J: Anagrelide therapy in pregnancy: report of a case of essential thrombocythemia. Ann. Hematol, 83, 2004, 726-727. IF 3,453
4. Doubek M, Vítek A, Mayer J: Reduced-intesity allografting for chronic myeloid leukemia in the first chronic phase. Hematologica, 89, 2004, 1, elt03 IF 3,4
5. Francová H, Trbušek M, Zapletalová P, Kuhrová V: New promoter mutations in the low-density lipoprotein receptor gene which induce familial hypercholesterolaemia phenotype:Molecular and functional analysis. J. Inherit. Metab. Dis, 27, 2004, 1, 523-528. IF 1,799
6. Hyánek, J, Kozák L, Hrabincová, E.,Trnka V, Kobilkova J, Doležal A, Soukup K, Zeman J, Šťastná S, Vaďurová L, Krijt J, Viletová H, Červená M, Paterová T: Maternal hyperphenylalaninemias in healthy Czech population of pregnant women: 30 years experience with screening, prevention and treatment. Bratisl Lek Listy, 105, 2004, 9, 291-298
7. Chrobáková T, Hermanová M, Kroupová I, Vondráček P, Maříková T, Mazanec R, Zámečník J, Staněk J, Havlová M, Fajkusová L: Mutations in Czech LGMD2A patients revealed by analysis of calpain3 mRNA and their phenotypic outcome. Neuromuscular disorders, 14, 2004, 659-665. IF 2,894
8. Křivanová A, Hájek R, Krejčí M, Ščudla V, Indrák V, Bačovský J, Büchler T, Svobodník A, Adam Z, Mayer, J, Vorlíček J. for the Czech Myeloma Group: Second Autologus Transplantation for Multiple Myeloma Patients Relapsing after the First Autograft – a Pilot Study for the Expwrimental Maintenance Therapies. Onkologie, 27, 2004, 275-279. IF 1,54
9. Lukašová E, Kořístek Z, Falk M et al. Methylation of histones in myeloid leukemias as a potential marker of granulocyte abnormalities. J Leukoc Biol. Epub, 26, 2004, 10, IF 4,18
10. Malaska J, Kunicka Z, Borsky M, Sklenickova M, Novotna M, Fajkusova L, Zaloudik J, Fajkus J: Telomerase as a diagnostic and predictive marker in colorectal carcinoma. Neoplasma, 51, 2004, 2, 90-96. IF 0,782
11. Michálek J, Bűchler T, Hájek R: T Lymphocyte Therapy of Cancer. Physiol Res, 53, 2004, 463 –469. IF 0,939
12. Pospíšilová Š, Brázda V, Kuchaříková K, Luciani M G, Hupp Ted R, Skládal P, Paleček E, Vojtěšek B: Activation of the DNA-binding ability of latent p53 protein by protein kinase C is abolisthed by protein kinse CK2. Biochem J, 378, 2004, 939-947. IF 4,101
13. Pospíšilová Š, Siligan C, Ban J, Jug G, Kovar H: Constitutive and DNA damage inducible activation of pig3 and MDM2 genes by tumor-derived p53 mutant C277Y. Mol Cancer Res, 20, 2004, 5, 296-304. IF 2,125
14. Skapova D, Racil Z, Dvorakova D, Minarikova D, Mayer J: Significance of qualitative PCR detection method for pre-emptive therapy of cytomegalovirus infection in patients after allogeneic hematopoietic stem cell transplantation--single-centre experience. J Clin Virol, 31, 2004, 4, 310-1. IF 2,02
15. Šenk P, Kozák L, Foret F: Capillary electrophoresis and mass spectrometry for screening of metabolic disorders in newborns. Electrophoresis, 25, 2004, 1447-1456. IF 4,04
16. Štros M, Muselíková-Polanská E, Pospíšilová Š, Strauss F: Specific recognition of hemicatenated DNA loops by tumor suppressor protein p53. Biochemistry, 43, 2004, 7215-7225. IF 3,999